OQRO

Feed News

Explore

Insider trades Fund holdings Congress trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 25K GILD derivative securities | OQRO

Insider trades

Insider trade

Officer exercised or converted 25K GILD derivative securities

Traded May 15, 2026 · Filed May 18, 2026

GILGilead SciencesGILD

25K
Shares · @ $66.64

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 15, 2026
Reporting period: Not applicable
Filed with the SEC: May 18, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001782135-26-000016

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

May 18, 2026, 9:45 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

GILEAD SCIENCES, INC.

Issuer CIK

882095

Ticker

GILD

Reporting person

Johanna Mercier

Relationship

Officer

Officer title

Chief Comm & Corp Aff Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

May 15, 2026

Transaction code

Shares / units

25,000

Price per share

$66.64

Acquired / disposed

Acquired (A)

Shares owned after

153,779

Ownership form

Direct

Amendment

Footnotes from the filing

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.

Around the same time

Officer sold ~$183K of Gilead Sciences

Scheduled in advance4mo ago

Officer sold ~$133K of Gilead Sciences

Scheduled in advance4mo ago

Officer sold ~$56K of Gilead Sciences

Scheduled in advance4mo ago